Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

Conditions:   Motion Sickness, Space;   Motion Sickness;   Sea Sickness Interventions:   Drug: DPI-386 Nasal Gel;   Drug: Placebo Nasal Gel Sponsors:   Repurposed Therapeutics, Inc.;   National Aeronautics and Space Administration (NASA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials